SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-012362
Filing Date
2021-05-20
Accepted
2021-05-20 16:33:35
Documents
35
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 192365
2 ex31-1.htm EX-31.1 16854
3 ex32-1.htm EX-32.1 6471
  Complete submission text file 0001493152-21-012362.txt   1124371

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE glsi-20210331.xml EX-101.INS 104308
5 XBRL SCHEMA FILE glsi-20210331.xsd EX-101.SCH 15755
6 XBRL CALCULATION FILE glsi-20210331_cal.xml EX-101.CAL 22940
7 XBRL DEFINITION FILE glsi-20210331_def.xml EX-101.DEF 55357
8 XBRL LABEL FILE glsi-20210331_lab.xml EX-101.LAB 104857
9 XBRL PRESENTATION FILE glsi-20210331_pre.xml EX-101.PRE 91773
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39555 | Film No.: 21944941
SIC: 2834 Pharmaceutical Preparations